These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 27553101)

  • 1. Prognostic Implications of Left Ventricular Scar Determined by Late Gadolinium Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.
    Suksaranjit P; McGann CJ; Akoum N; Biskupiak J; Stoddard GJ; Kholmovski EG; Navaravong L; Rassa A; Bieging E; Chang L; Haider I; Marrouche NF; Wilson BD
    Am J Cardiol; 2016 Oct; 118(7):991-7. PubMed ID: 27553101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .
    Neilan TG; Shah RV; Abbasi SA; Farhad H; Groarke JD; Dodson JA; Coelho-Filho O; McMullan CJ; Heydari B; Michaud GF; John RM; van der Geest R; Steigner ML; Blankstein R; Jerosch-Herold M; Kwong RY
    J Am Coll Cardiol; 2013 Dec; 62(23):2205-14. PubMed ID: 23994399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental LV LGE on CMR Imaging in Atrial Fibrillation Predicts Recurrence After Ablation Therapy.
    Suksaranjit P; Akoum N; Kholmovski EG; Stoddard GJ; Chang L; Damal K; Velagapudi K; Rassa A; Bieging E; Challa S; Haider I; Marrouche NF; McGann CJ; Wilson BD
    JACC Cardiovasc Imaging; 2015 Jul; 8(7):793-800. PubMed ID: 26093929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation.
    Stegmann C; Jahnke C; Paetsch I; Hilbert S; Arya A; Bollmann A; Hindricks G; Sommer P
    Europace; 2018 Oct; 20(10):1606-1611. PubMed ID: 29420707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
    Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
    Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the prognostic relevance of myocardial ischaemia and scar by cardiac magnetic resonance in patients with and without diabetes mellitus.
    Giusca S; Kelle S; Nagel E; Buss SJ; Voss A; Puntmann V; Fleck E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):812-20. PubMed ID: 26358695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.
    Kwong RY; Chan AK; Brown KA; Chan CW; Reynolds HG; Tsang S; Davis RB
    Circulation; 2006 Jun; 113(23):2733-43. PubMed ID: 16754804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    King JB; Azadani PN; Suksaranjit P; Bress AP; Witt DM; Han FT; Chelu MG; Silver MA; Biskupiak J; Wilson BD; Morris AK; Kholmovski EG; Marrouche N
    J Am Coll Cardiol; 2017 Sep; 70(11):1311-1321. PubMed ID: 28882227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Prognostic Value of Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With and Without Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting.
    Lee SA; Yoon YE; Kim JE; Park JJ; Oh IY; Yoon CH; Suh JW; Kim JS; Chun EJ; Cho YS; Youn TJ; Lim C; Cho GY; Chae IH; Park KH; Choi DJ; Choi SI
    Am J Cardiol; 2016 Dec; 118(11):1647-1654. PubMed ID: 27742424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of cardiac magnetic resonance late gadolinium enhancement in patients with atrial fibrillation.
    Chrispin J; Ipek EG; Habibi M; Yang E; Spragg D; Marine JE; Ashikaga H; Rickard J; Berger RD; Zimmerman SL; Calkins H; Nazarian S
    Europace; 2017 Mar; 19(3):371-377. PubMed ID: 26965439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of unrecognized myocardial scar in the non-culprit territories by cardiac magnetic resonance imaging in patients with acute myocardial infarction.
    Omori T; Kurita T; Dohi K; Takasaki A; Nakata T; Nakamori S; Fujimoto N; Kitagawa K; Hoshino K; Tanigawa T; Sakuma H; Ito M
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):108-116. PubMed ID: 28950314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.
    Gaztanaga J; Paruchuri V; Elias E; Wilner J; Islam S; Sawit S; Viles-Gonzalez J; Sanz J; Garcia MJ
    Am J Cardiol; 2016 Oct; 118(7):1063-8. PubMed ID: 27614850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kato S; Foppa M; Roujol S; Basha T; Berg S; Kissinger KV; Goddu B; Manning WJ; Nezafat R
    Int J Cardiol; 2016 Jan; 203():848-54. PubMed ID: 26599750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis evaluation of chronic inflammatory cardiomyopathy with ring-like late gadolinium enhancement.
    Wang H; Bo K; Gao Y; Zhou Z; Xu L
    ESC Heart Fail; 2023 Jun; 10(3):1735-1744. PubMed ID: 36843322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.